These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1419548)

  • 41. Beneficial effects of fluvoxamine for hemiballism in a patient with depressive disorder: a case report.
    Cayköylü A; Albayrak Y; Uğurlu GK; Ekinci O
    Acta Neurol Belg; 2011 Mar; 111(1):62-5. PubMed ID: 21510237
    [No Abstract]   [Full Text] [Related]  

  • 42. Fluvoxamine-methadone interaction.
    Alderman CP; Frith PA
    Aust N Z J Psychiatry; 1999 Feb; 33(1):99-101. PubMed ID: 10197892
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Polydipsia induced by fluvoxamine.
    Benazzi F; Mazzoli M
    Pharmacopsychiatry; 1993 Mar; 26(2):63. PubMed ID: 8378415
    [No Abstract]   [Full Text] [Related]  

  • 44. A comparative study of amitriptyline and fluvoxamine in migraine prophylaxis.
    Bánk J
    Headache; 1994 Sep; 34(8):476-8. PubMed ID: 7960733
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of antidepressant demethylation and hydroxylation by fluvoxamine in depressed patients.
    Härtter S; Wetzel H; Hammes E; Hiemke C
    Psychopharmacology (Berl); 1993; 110(3):302-8. PubMed ID: 7831423
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sodium valproate augmentation of fluoxetine or fluvoxamine effects.
    Corrigan FM
    Biol Psychiatry; 1992 Jun; 31(11):1178-9. PubMed ID: 1525286
    [No Abstract]   [Full Text] [Related]  

  • 47. Toxicity of tricyclic antidepressants: are there important differences?
    Dorman T
    J Int Med Res; 1985; 13(2):77-83. PubMed ID: 3888729
    [No Abstract]   [Full Text] [Related]  

  • 48. Meta-analyses of the efficacy and tolerability of the tricyclic antidepressant lofepramine.
    Kerihuel JC; Dreyfus JF
    J Int Med Res; 1991; 19(3):183-201. PubMed ID: 1834491
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Review of fluvoxamine safety database.
    Wagner W; Plekkenpol B; Gray TE; Vlaskamp H; Essers H
    Drugs; 1992; 43 Suppl 2():48-53; discussion 53-4. PubMed ID: 1378374
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of fluvoxamine treatment on cognitive functioning in the alcoholic Korsakoff syndrome.
    O'Carroll RE; Moffoot AP; Ebmeier KP; Goodwin GM
    Psychopharmacology (Berl); 1994 Sep; 116(1):85-8. PubMed ID: 7862935
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dyskinesia associated with fluvoxamine.
    Arya DK; Szabadi E
    J Clin Psychopharmacol; 1993 Oct; 13(5):365-6. PubMed ID: 8227498
    [No Abstract]   [Full Text] [Related]  

  • 52. The effects of dothiepin on subjects with rheumatoid arthritis and depression.
    Chuck AJ; Swannell AJ; House AO; Pownall R
    Rheumatology (Oxford); 2000 Dec; 39(12):1425-7. PubMed ID: 11136890
    [No Abstract]   [Full Text] [Related]  

  • 53. [Depressive disorders in general medical practice in KOMPAS study: outlook of a cardiologist].
    Oganov RG; Pogosova GV; Shal'nova SA; Deev AD
    Kardiologiia; 2005; 45(8):37-43. PubMed ID: 16091639
    [No Abstract]   [Full Text] [Related]  

  • 54. Pharmacokinetics of fluoxetine and fluvoxamine in depressed patients: personal results.
    Bouquet S; Vandel S; Bertschy G; Bonin B; Vandel B; Sechter D; Bizouard P
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():82A-83A. PubMed ID: 1499006
    [No Abstract]   [Full Text] [Related]  

  • 55. Are SSRI antidepressants clinically homogeneous?
    Carroll BJ
    Lancet; 1994 Aug; 344(8921):550. PubMed ID: 7914647
    [No Abstract]   [Full Text] [Related]  

  • 56. Fluvoxamine-induced theophylline toxicity.
    DeVane CL; Markowitz JS; Hardesty SJ; Mundy S; Gill HS
    Am J Psychiatry; 1997 Sep; 154(9):1317-8. PubMed ID: 9286199
    [No Abstract]   [Full Text] [Related]  

  • 57. Compliance with tricyclic antidepressants: the value of four different methods of assessment.
    George CF; Peveler RC; Heiliger S; Thompson C
    Br J Clin Pharmacol; 2000 Aug; 50(2):166-71. PubMed ID: 10930969
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fluvoxamine and weight loss.
    Fernstrom MH; Massoudi M; Kupfer DJ
    Biol Psychiatry; 1988 Dec; 24(8):948-9. PubMed ID: 3148332
    [No Abstract]   [Full Text] [Related]  

  • 59. Repurposing psychopharmacology: A two-way street?
    Young AH
    J Psychopharmacol; 2021 Dec; 35(12):1439-1440. PubMed ID: 34872403
    [No Abstract]   [Full Text] [Related]  

  • 60. Fluvoxamine for COVID-19 outpatients: For the time being, we might prefer to curb our optimism.
    Trkulja V
    Br J Clin Pharmacol; 2022 Oct; 88(10):4654-4656. PubMed ID: 35822436
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.